BBR Partners »

Lexicon Pharmaceuticals shares owned by BBR Partners

Quarter-by-quarter ownership of Lexicon Pharmaceuticals (LXRX) shares owned by BBR Partners from 13F filings

Historical chart of BBR Partners investment in Lexicon Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Lexicon Pharmaceuticals held by BBR Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lexicon Pharmaceuticals by BBR Partners

Quarter filed Position value Share count Share price at filing
2024-03-31 $72k 30k 2.40

More positions owned by BBR Partners

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Core S&p500 Etf (IVV)
United Parcel Service CL B (UPS)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Apple (AAPL)
Microsoft Corporation (MSFT)
Vanguard Index Fds Total Stk Mkt (VTI)
Kkr & Co Cl A (KKR)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Vanguard World Fds Inf Tech Etf (VGT)
Ishares Tr Russell 3000 Etf (IWV)
Alphabet Cap Stk Cl A (GOOGL)
Philip Morris International (PM)
Abbvie (ABBV)
Berkshire Hathaway Inc Del Cl B New (BRK.B)

View all positions for BBR Partners

Top funds holding Lexicon Pharmaceuticals

Artal Group
FMR
BlackRock
Vanguard Group
OrbiMed Advisors
Geode Capital Management
NEA Management Company
Susquehanna International
Gail Mannix
BVF
Ameriprise Financial
Cubist Systematic Strategies
Schonfeld Strategic Advisors
Charles Schwab Investment Management
Northern Trust

View all funds holding Lexicon Pharmaceuticals